SCHEMBL6236262

SCHEMBL6236262

c1csc(-c2nc3cncnc3nc2-c2cccs2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 9/20 0.56
ALDH1A1 P00352 9/20 0.56
CASP1 P29466 9/20 0.56
CASP7 P55210 9/20 0.56
CYP3A4 P08684 8/20 0.56
CYP2C9 P11712 8/20 0.56
HSD17B10 Q99714 7/20 0.56
USP2 O75604 7/20 0.56
MEN1 O00255 5/20 0.56
KMT2A Q03164 5/20 0.56
CLK4 Q9HAZ1 4/20 0.56
HIF1A Q16665 1/20 0.56
CYP2C19 P33261 7/20 0.52
TSHR P16473 3/20 0.52
RPS6KB2 Q9UBS0 7/20 0.51
HPGD P15428 2/20 0.51
RECQL P46063 1/20 0.49
PIK3CG P48736 1/20 0.49
MAPK1 P28482 2/20 0.48
GLA P06280 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8218853 0.84 CYP1A2 (0.52) CYP1A2ALDH1A1CASP1CASP7CYP3A4
SCHEMBL8225185 0.84 CYP1A2 (0.49) CYP1A2ALDH1A1CASP1CASP7CYP3A4
SCHEMBL8380558 0.82 CYP1A2 (0.46) CYP1A2ALDH1A1CASP1CASP7CYP3A4
SCHEMBL8381234 0.82 CYP1A2 (0.49) CYP1A2ALDH1A1CASP1CASP7CYP3A4
SCHEMBL7919609 0.81 CYP1A2 (0.46) CYP1A2ALDH1A1CASP1CASP7CYP3A4
SCHEMBL7917795 0.81 CYP1A2 (0.48) CYP1A2ALDH1A1CASP1CASP7CYP3A4
SCHEMBL10786959 0.79 ALDH1A1 (0.59) CYP1A2ALDH1A1CASP1CASP7CYP3A4
SCHEMBL8499230 0.79 ALDH1A1 (0.59) CYP1A2ALDH1A1CASP1CASP7CYP3A4
SCHEMBL6237157 0.77 RPS6KB2 (0.54) ALDH1A1CASP1CASP7CYP3A4CYP2C9
SCHEMBL6236374 0.76 RPS6KB2 (0.54) CYP1A2ALDH1A1CASP1CASP7CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005007099-A2 PKB INHIBITORS AS ANTI-TUMOR AGENTS IMCLONE SYSTEMS INCORPORATED (US) 2005-01-27 WO disclosed